Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
life sciences
national
2
×
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
2025
accent therapeutics
ad-comm
aducanumab
affimed
akcea therapeutics
allogene therapeutics
What
bio
ipo
2
×
new
2
×
roundup
2
×
activity
allogene
approvals
biogen
cancer
clamped
covid
crispr
delays
developing
diversity
economic
fast
fda
hot
immunotherapy
including
investors
isn’t
juno
lot
medicines
million
nearly
oric’s
remains
shares
showing
snapped
spread
testing
therapeutics
ticket
utero
work
years
Language
unset
Current search:
roundup
×
novartis
×
national
×
ipo
×
new
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More